QA: Sio Gene Therapies Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001636050_2018_Sio_Gene_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001636050, Sio Gene Therapies Inc

  xvar xval
0 AssetsCurrent 219,688,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 142,000
3 remainder_Assets 2,709,000
4 LiabilitiesCurrent 46,266,000
5 LiabilitiesNoncurrent 51,436,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 45,721,000
9 ResearchAndDevelopmentExpense 134,778,000
10 remainder_Expenses 83,000
11 remainder_Revenues 0
12 remainder_NetIncome -369,000
13 remainder_ComprehensiveNetIncome 378,000
  yvar yval
0 Assets 222,539,000
1 Liabilities 97,702,000
2 Expenses 180,582,000
3 Revenues 0
4 StockholdersEquity 124,837,000
5 NetIncome -180,951,000
6 ComprehensiveNetIncome -180,762,000
7 BaseVar 250,785,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.571
9 EconomicCapitalRatio 1.94

Edgar->Model Mapping

Feature Distribution

Change over Time